UK markets closed
NIKKEI 225
28,743.25-121.07(-0.42%)HANG SENG
28,540.83-557.46(-1.92%)CRUDE OIL
64.85-1.24(-1.88%)
Ironwood Pharmaceuticals, Inc. (IRWD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.51+0.40 (+3.96%)
As of 2:20PM EST. Market open.
| Previous close | 10.11 |
| Open | 10.51 |
| Bid | 10.53 x 900 |
| Ask | 10.54 x 1100 |
| Day's range | 10.34 - 10.71 |
| 52-week range | 7.99 - 12.55 |
| Volume | 2,258,216 |
| Avg. volume | 1,816,475 |
| Market cap | 1.692B |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | 15.92 |
| EPS (TTM) | 0.66 |
| Earnings date | 04 May 2021 - 10 May 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.00 |
- Simply Wall St.
Edward Owens Is The Independent Director of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) And They Just Picked Up 5.9% More Shares
Potential Ironwood Pharmaceuticals, Inc. ( NASDAQ:IRWD ) shareholders may wish to note that the Independent Director...
- Motley Fool
3 Undervalued Biotechs Worth Adding to Your Watch List
If you're like me, your investment watch list is overflowing with dozens of stocks and price alerts. Let's examine three biotechs trading at lower than average valuations and consider whether they might be worth putting on your watch list. Supernus Pharmaceuticals (NASDAQ: SUPN) makes drugs that treat disorders of the central nervous system, including epilepsy and Parkinson's disease.
- Business Wire
Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, announced that management will be presenting at the following investor conferences:
© 2021 Verizon Media. All rights reserved.
